Marisa E Hilliard1, Charles G Minard2, David G Marrero3, Maartje de Wit4, Debbe Thompson5, Stephanie N DuBose6, Alandra Verdejo6, Roshanak Monzavi7, R Paul Wadwa8, Sarah S Jaser9, Barbara J Anderson1. 1. Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital. 2. Dan L Duncan Institute for Clinical and Translational Research, Baylor College of Medicine. 3. University of Arizona Health Sciences. 4. Department of Medical Psychology, Amsterdam UMC, Vrije Universiteit Amsterdam. 5. USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine. 6. Jaeb Center for Health Research. 7. Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles and Keck School of Medicine of University of Southern California. 8. Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus. 9. Department of Pediatrics, Vanderbilt University Medical Center.
Abstract
OBJECTIVE: To develop and validate new measures of diabetes-specific health-related quality of life (HRQOL) for people with type 1 diabetes (T1D) that are brief, developmentally appropriate, and usable in clinical research and care. Here we report on the phases of developing and validating the self-report Type 1 Diabetes and Life (T1DAL) measures for children (age 8-11) and adolescents (age 12-17). METHODS: Measure development included qualitative interviews with youth and parents (n = 16 dyads) followed by piloting draft measures and conducting cognitive debriefing with youth (n = 9) to refine the measures. To evaluate the psychometric properties, children (n = 194) and adolescents (n = 257) at three T1D Exchange Clinic Network sites completed the age-appropriate T1DAL measure and previously validated questionnaires measuring related constructs. Using psychometric data, the investigators reduced the length of each T1DAL measure to 21 and 23 items, respectively, and conducted a final round of cognitive debriefing with six children and adolescents. RESULTS: The T1DAL measures for children and adolescents demonstrated good internal consistency (α = 0.84 and 0.89, respectively) and test-retest reliability (r = 0.78 and 0.80, respectively). Significant correlations between the T1DAL scores and measures of general quality of life, generic and diabetes-specific HRQOL, diabetes burden, and diabetes strengths demonstrated construct validity. Correlations with measures of self-management (child and adolescent) and glycemic control (adolescent only) demonstrated criterion validity. Factor analyses indicated four developmentally specific subscales per measure. Participants reported satisfaction with the measures. CONCLUSIONS: The new T1DAL measures for children and adolescents with T1D are reliable, valid, and suitable for use in care settings and clinical research.
OBJECTIVE: To develop and validate new measures of diabetes-specific health-related quality of life (HRQOL) for people with type 1 diabetes (T1D) that are brief, developmentally appropriate, and usable in clinical research and care. Here we report on the phases of developing and validating the self-report Type 1 Diabetes and Life (T1DAL) measures for children (age 8-11) and adolescents (age 12-17). METHODS: Measure development included qualitative interviews with youth and parents (n = 16 dyads) followed by piloting draft measures and conducting cognitive debriefing with youth (n = 9) to refine the measures. To evaluate the psychometric properties, children (n = 194) and adolescents (n = 257) at three T1D Exchange Clinic Network sites completed the age-appropriate T1DAL measure and previously validated questionnaires measuring related constructs. Using psychometric data, the investigators reduced the length of each T1DAL measure to 21 and 23 items, respectively, and conducted a final round of cognitive debriefing with six children and adolescents. RESULTS: The T1DAL measures for children and adolescents demonstrated good internal consistency (α = 0.84 and 0.89, respectively) and test-retest reliability (r = 0.78 and 0.80, respectively). Significant correlations between the T1DAL scores and measures of general quality of life, generic and diabetes-specific HRQOL, diabetes burden, and diabetes strengths demonstrated construct validity. Correlations with measures of self-management (child and adolescent) and glycemic control (adolescent only) demonstrated criterion validity. Factor analyses indicated four developmentally specific subscales per measure. Participants reported satisfaction with the measures. CONCLUSIONS: The new T1DAL measures for children and adolescents with T1D are reliable, valid, and suitable for use in care settings and clinical research.
Authors: Patricia Davidson; Jacqueline LaManna; Jean Davis; Maria M Ojeda; Suzanne Hyer; Jane K Dickinson; Andrew Todd; Tamara M Hammons; Shahariar Mohammed Fahim; Cassidi C McDaniel; Cynthia A McKee; Jennifer N Clements; Kirsten Yehl; Michelle L Litchman; Julia E Blanchette; Jan Kavookjian Journal: Sci Diabetes Self Manag Care Date: 2022-01-14
Authors: Amit Shapira; Kara R Harrington; Eveline R Goethals; Lisa K Volkening; Lori M Laffel Journal: Diabet Med Date: 2021-06-19 Impact factor: 4.213
Authors: Marisa E Hilliard; Charles G Minard; David G Marrero; Maartje de Wit; Stephanie N DuBose; Alandra Verdejo; Sarah S Jaser; Davida Kruger; Roshanak Monzavi; Viral N Shah; R Paul Wadwa; Ruth S Weinstock; Debbe Thompson; Viena T Cao; Barbara J Anderson Journal: Fam Syst Health Date: 2021-04-26 Impact factor: 1.569